Tactic Pharma LLC - Insider Trading & Ownership

Location
598 Rockefeller Rd., Lake Forest, IL
Summary
The estimated value of insider holdings of Tactic Pharma LLC is at least $17.3M dollars as of September 26, 2025. Tactic Pharma LLC is the 10%+ Owner of Monopar Therapeutics and owns shares of Monopar Therapeutics (MNPR) stock worth about $17.3M.
Signature
/s/ Chandler Robinson, Attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Tactic Pharma LLC

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
MNPR Monopar Therapeutics 10%+ Owner $17.3M -$36.2M -67.6% Sep 24, 2025

Insider Transactions Reported by Tactic Pharma LLC:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.